Low Risk of Drug Interaction between the Cyclophilin Inhibitor Debio-025 and (Peg) IFNa/ribavirin in HCV

L. Novaroli, V. Nicolas, M.P. Simonin, A. Menetrey, N. Treijtel, I. A.T.M. Meerts, H. Porchet, R. Crabbé

17th APASL Conference, Viral Hepatitis and Hepatocellular Carcinoma – March 2007 –  Kyoto/Japan 2007 (Abstract)